Olympus Corp., a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today the launch of the ScopeLocker Air endoscope drying cabinet, offering a new drying option for healthcare facilities. Drying endoscope channels is a critical component of reprocessing. The ScopeLocker Air endoscope drying cabinet, manufactured by Capsa Healthcare and distributed by Olympus Corp., helps facilitate the drying process and is desi

Aesculap, Inc. (Aesculap), an industry leader in sterile processing and operating room solutions, is pleased to announce the extension of its partnership with Ascendco Health, an innovative health tech company, for another ten years. The partnership, which began five years ago, aims to transform perioperative workflows by combining Aesculap's industry-leading expertise in surgical instrumentation and sterile processing with Ascendco Health's proprietary asset management technology.

Medline today announced it has entered into a distribution and supply agreement with TenderHeart Health Outcomes, a Texas-based provider dedicated to providing high-quality medical supplies and innovative patient-centric programs. As part of the agreement, TenderHeart is using the Medline Home Direct™ Program to ship medical supplies directly to TenderHeart's patients' homes; these include enteral feeding, urology, ostomy and wound care supplies, breast pumps, pediatri

Avant Technologies, Inc. and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the companies are exploring options to integrate the early detection of dementia into Ainnova's proprietary, AI-powered platform technology, Vision AI.  The addition would reinforce the Company's mission of expanding AI-powered early detection and preventative heal

Abbott today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne™ transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease. This life-changing therapy is available for patients whose mitral valves are not functioning properly due to severe mitral annular calcification (MAC), a buildup of calcium within the ring-like structure (known as an annulus) that supports the mitral valve. The complex nature o

Perimeter Medical Imaging AI, Inc. a commercial-stage medical technology company, is pleased to announce that it has entered into a Development Support Agreement ("DSA") with Salt Lake City-based Intermountain Health, the largest nonprofit health system in the Intermountain West. This agreement creates the framework for the two organizations to partner on a number of future studies evaluating the potential value of using Perimeter's OCT and collecting additional data to support

AI Medical Technology (AIM) has received CE mark approval for Dermalyser, its diagnostic decision support tool for melanoma detection. Designed for use on smartphones attached to a dermatoscope, the AI-powered tool has demonstrated superior performance compared to experienced dermatologists and is now cleared for use across Europe. Dermalyser is a stand-alone Medical Device Software (MDSW). Its clinical performance was validated through AI-DSMM, a real-world trial conducted at 36 pr

Esaote, a leading company in the field of medical diagnostic imaging, has presented the world premiere of the new MyLab™Heron ultrasound system at the Congress organized in Rimini from May 23 to 25 May by SCIVAC, the largest Veterinary Scientific Society in Italy, the objective of which is the scientific and professional education of veterinarians. MyLab™Heron is the latest result of Esaote's research activity in high-performance portable ultrasound systems, in which

Comac Medical Group ("Group"), based in the UK and backed by EdgeCap Partners, announced today the acquisition of ILIFE Consulting ("ILIFE"), a specialized Contract Research Organization (CRO) headquartered in Paris, France, renowned for its expertise in oncology, rare diseases, and complex biotech clinical trials. The transaction represents a significant milestone for the Group on its journey to becoming the leading pan-European full-service CRO partner for smal

Lunit, a leading provider of AI for cancer diagnostics and therapeutics, today announced major milestones in the United States, one year after its acquisition of Volpara Health Technologies. Since acquiring Volpara, Lunit has significantly expanded its presence across North America. By June 2025, Lunit's AI solutions for digital breast tomosynthesis (Lunit INSIGHT DBT) and mammography analysis (Lunit INSIGHT MMG) will be deployed at over 200 imaging centers and hospitals across